none9noPURPOSE: Clinical trials have shown that evidence-based secondary prevention medications reduce mortality after acute myocardial infarction (AMI). Yet, these medications are generally underused in daily practice, and older people are often excluded from drug trials. The purpose of this study was to examine whether the relationship between adherence to evidence-based drugs and post-AMI mortality varies with increasing age. METHODS: The study population was defined as all residents in the Local Health Authority of Bologna (Italy) hospitalized for AMI between January 1, 2008 and June 30, 2011, and followed up until December 31, 2012. Medication adherence was calculated as the proportion of days covered (PDC) for filled prescriptions of...
Prescription and adherence to statin treatment hold distinct but complementary roles in the benefici...
BACKGROUND: Prior studies reported high guideline adherence for secondary prevention medications (SP...
Background: observational studies suggest that older patients are less likely to receive secondary p...
Background Angiotensin-converting enzyme (ACE) inhibitors/angiotensin II receptor blockers (ARB), be...
PURPOSE Secondary medication prevention after acute myocardial infarction (MI) is strongly recommen...
Aim To assess whether in individuals aged 80 years or older adherence to statins is accompanied by a...
Background Secondary prevention medications are often not prescribed to frail, older adults followin...
BACKGROUND: There are limited data informing the optimal treatment strategy for acute myocardial inf...
AIMS: Persistent use of guideline-recommended drugs after acute myocardial infarction (AMI) is frequ...
ObjectivesWe sought to assess the relationship between increasing use of cardiovascular medications ...
OBJECTIVE: To explore the effect of initiating statins for secondary prevention after a first myocar...
OBJECTIVE: To explore the effect of initiating statins for secondary prevention after a first myocar...
AIMS: Experiencing an acute myocardial infarction (AMI) is a life-threatening event and use of stati...
Background and Objective: Conflicting findings from studies evaluating the association between use o...
Abstract Background Elderly patients with coronary artery disease (CAD) frequently complicated with ...
Prescription and adherence to statin treatment hold distinct but complementary roles in the benefici...
BACKGROUND: Prior studies reported high guideline adherence for secondary prevention medications (SP...
Background: observational studies suggest that older patients are less likely to receive secondary p...
Background Angiotensin-converting enzyme (ACE) inhibitors/angiotensin II receptor blockers (ARB), be...
PURPOSE Secondary medication prevention after acute myocardial infarction (MI) is strongly recommen...
Aim To assess whether in individuals aged 80 years or older adherence to statins is accompanied by a...
Background Secondary prevention medications are often not prescribed to frail, older adults followin...
BACKGROUND: There are limited data informing the optimal treatment strategy for acute myocardial inf...
AIMS: Persistent use of guideline-recommended drugs after acute myocardial infarction (AMI) is frequ...
ObjectivesWe sought to assess the relationship between increasing use of cardiovascular medications ...
OBJECTIVE: To explore the effect of initiating statins for secondary prevention after a first myocar...
OBJECTIVE: To explore the effect of initiating statins for secondary prevention after a first myocar...
AIMS: Experiencing an acute myocardial infarction (AMI) is a life-threatening event and use of stati...
Background and Objective: Conflicting findings from studies evaluating the association between use o...
Abstract Background Elderly patients with coronary artery disease (CAD) frequently complicated with ...
Prescription and adherence to statin treatment hold distinct but complementary roles in the benefici...
BACKGROUND: Prior studies reported high guideline adherence for secondary prevention medications (SP...
Background: observational studies suggest that older patients are less likely to receive secondary p...